Combination therapy with methotrexate, vincristine, polyethylene-glycol conjugated-asparaginase, and prednisone in the treatment of patients with refractory or recurrent acute lymphoblastic leukemia

Cancer

Volumn 86, Issue 7, 1999, Pages 1203-1209

  Aguayo, Alvaro ^a   Cortes, Jorge ^a   Thomas, Deborah ^a   Pierce, Sherry ^a   Keating, Michael ^a   Kantarjian, Hagop ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Acute lymphoblastic leukemia; L asparaginase; Polyethylene glycol conjugated (PEG) asparaginase; Recurrent; Refractory

Indexed keywords

ASPARAGINASE; MACROGOL; METHOTREXATE; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; RECURRENT CANCER; TREATMENT INDICATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASPARAGINASE; DRUG ADMINISTRATION SCHEDULE; ENZYMES, IMMOBILIZED; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; METHOTREXATE; MIDDLE AGED; PHILADELPHIA CHROMOSOME; POLYETHYLENE GLYCOLS; PREDNISONE; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME; VINCRISTINE;

EID: 0033214796     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19991001)86:7<1203::AID-CNCR15>3.0.CO;2-3     Document Type: Article

References (27)

1. Henderson ES, Hoelzer D, Freeman AL. The treatment of acute lymphoblastic leukemia. In: Henderson ES, Lister TA, editors. Leukemia Philadelphia: W. B. Saunders Company, 1990:443-84
2. Pui CH. Childhood leukemias. N Engl J Med 1995;332(24): 1618-30.
3. Bassan R, Lerede T, Barbui T. Strategies for the treatment of recurrent acute lymphoblastic leukemia in adults. Haematologica 1996;81:20-36.
4. Testi AM, Moleti ML, Giona F, Iori AP, Meloni G, Miniero R, et al. Treatment of primary refractory or relapsed acute lymphoblastic leukemia (ALL) in children. Ann Oncol 1992; 3(9):765-7.
5. Thomas D, Kantarjian H, Keating MJ, O'Brien S, Pierce S, Beran M, et al. Adult acute lymphocytic leukemia (ALL) in first relapse: characteristics, outcome, and prognosis with salvage therapy [abstract 294]. Blood 1996;88(Suppl 1):76a.
6. Weisdorf DJ, Billet AL, Hannan P, Ritz J, Sallan SE, Steinbuch M, et al. Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia. Blood 1997;90(8):2962-8.
7. Sur P, Femandes DJ, Kute TE, Capizzi RL. L-Asparaginase-induced modulation of methotrexate polyglutamylation in murine leukemia L5178Y. Cancer Res 1987;47:1313-8.
8. Lobel JS, O'Brien RT, McIntosh S, Aspenes GT, Capizzi RL. Methotrexate and asparaginase combination chemotherapy in refractory acute lymphoblastic leukemia in childhood. Cancer 1979;43:1089-94.
9. Capizzi RL. Asparaginase revisited. Leuk Lymphoma 1993; 10:147-50.
10. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposal for the classification of acute leukemias: French-American-British (FAB) co-operative group. Br J Haematol 1976;33:451-8.
11. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. The morphological classification of acute lymphoblastic leukaemia: concordance among observers and clinical correlations. Br J Haematol 1981;47(4):553-61.
12. Henderson ES, Afshani E. Clinical manifestations and diagnosis. In: Henderson ES, Lister TA, editors. Leukemia. Philadelphia: W. B. Saunders Company, 1990:291-359.
13. Traweek ST. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol 1993;99(4):504-12.
14. Zubrod CG, Schneiderman M, Frei E III. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 1960;11:7-33.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
16. Asselin BL, Within JC, Coppola DJ, Rupp IP, Sallan SE, Cohen HC. Comparative pharmacokinetic studies of three asparaginase preparations. J Clin Oncol 1993;11(9): 1780-6.
17. Asselin BL, N'Dive S, Welle S, Sallan SE. Significant differences in asparagine depletion following L-asparaginase therapy with E Coli- versus Erwinia-derived preparations [abstract 1489]. Blood 1997;90(Suppl 1):334a.
18. Frankel SR, Kurtzberg J, DeOleveira D, Dodge R, Peterson B, Powell BL, et al. Toxicity and pharmacokinetics of PEG-asparaginase (PEG-asp) in newly diagnosed adult acute lymphoblastic leukemia (ALL): CALGB 9511 [abstract 1491]. Blood 1997;90(Suppl 1):334a.
19. Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D, Bertino JR. Intrinsic and acquired resistance to methotrexate in acute leukemia. N Engl J Med 1996;335(14):1041-8.
20. Capizzi RL. Schedule-dependent synergism and antagonism between methotrexate and asparaginase. Biochem Pharmacol 1974;23(Suppl 2):151-61.
21. Capizzi RL, Castro O, Aspnes G, Bobrow S, Bertino J, Finch S, et al. Treatment of acute of acute lymphocytic leukemia (ALL) with intermittent high dose methotrexate and asparaginase (A'ase). Proc Am Soc Clin Oncol 1974;15:182.
22. Yap BS, McCredie KB, Keating MJ, Bodey GP, Freireich EJ. Asparaginase and methotrexate combination chemotherapy in relapsed acute lymphoblastic leukemia in adults. Cancer Treat Rep 1981;65(Suppl 1):83-7.
23. Esterhay RJ, Wiernik PH, Grove WR, Markus SD, Wesley MN. Moderate dose of methotrexate, vincristine, asparaginase, and dexamethasone for treatment of adult acute lymphocytic leukemia. Blood 1982;59(2):334-5.
24. Douer D, Watkins K, Periclou LA, Cohen LJ, Avramis VI. PEG L-asparaginase (PEG-ASase) containing chemotherapy in untreated acute lymphoblastic leukemia adults. Proc Meet Am Soc Clin Oncol 1997;16:A102.
25. Larson RA, Fretzin MH, Dodge RK, Schiffer CA. Hypersensitivity reactions to L-asparaginase do not impact on the remission duration of adults with acute lymphoblastic leukemia. Leukemia 1998;12:660-5.
26. Ohnuma T, Holland JF, Sinks LF. Biochemical and pharmacological studies with L-asparaginase in man. Cancer Res 1970;30:2297-305.
27. Leonard JV, Kay JDS. Acute encephalopathy and hyperammonaemia complicating treatment of acute lymphoblastic leukaemia with asparaginase. Lancet 1986;1:162-3.